Gallium-68-prostate specific membrane antigen (68Ga-PSMA) positron emission tomography/computed tomography (PET/CT) imaging is revolutionizing the management of prostate cancer since its advent in 2013 [1]. The gene discussed is FOLH1; the disease is Familial prostate cancer.